Status:
COMPLETED
Mazindol for Cocaine Abuse - 2
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
September 1 1994
Trial Type :
INTERVENTIONAL
End Date :
August 1 1999
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000277
Start Date
September 1 1994
End Date
August 1 1999
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06519